Undisclosed CAR-T cell therapy / Inceptor Bio - LARVOL DELTA

Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST Platform (PRNewswire) - "Inceptor Bio...and GRIT Bio...announced a strategic partnership to advance IB-T101, a potentially best-in-class CAR-T therapy targeting solid tumors....Under the terms of the agreement, Inceptor Bio will grant GRIT Bio an exclusive license for IB-T101 in China. GRIT Bio will oversee development, manufacturing, and commercialization."

Licensing / partnership • Oncology • Solid Tumor